U.S. health officials on Friday approved a closely watched Alzheimer’s drug that’s been shown to modestly slow the early stages of the brain-robbing disease, albeit with potential safety risks that doctors and patients will have to weigh carefully. The drug, Leqembi, is the first that’s been convincingly shown to slow the decline in memory and … continue reading -> “US Approves Alzheimer’s Drug That Modestly Slows Disease”